secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001104659-25-054856
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences receives Nasdaq delisting notice; intends to appeal
------------------------------------------------------------------------

- Nasdaq determined to delist RSLS for failing to meet $2.5M stockholders' equity requirement by May 27, 2025 extension deadline.
- Trading will be suspended June 6 unless the company appeals by June 4; a Form 25-NSE will then remove securities from listing.
- Company intends to appeal to a Nasdaq hearings panel, which would stay suspension pending decision.
- No assurance hearings panel will grant continued listing or that compliance with listing rules can be maintained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925054856/0001104659-25-054856-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925054856/tm2516583d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-054856

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer